SEC Filing Document

Company: BIOVENTRIX, INC.
Ticker: 
CIK: 1283259
Filing Type: S-1
Document Type: EX-10.8
Date Filed: 2026-02-12
Accession Number: 0001493152-26-006407
Exchange: 
SIC Code: 3841
SIC Description: Surgical & Medical Instruments & Apparatus
URL: https://www.sec.gov/Archives/edgar/data/1283259/000149315226006407/ex10-8.htm

Chunk 11 of 14
Word Count: 1490
Character Count: 9654

Document Content:

The Company shall use commercially reasonable efforts to ensure that the Cybersecurity Solutions (x) are up-to-date and include industry-standard protections (e.g., antivirus, endpoint detection and response and threat hunting), (y) to the extent determined necessary by the Company or the Board of Directors, are backed by a breach prevention warranty from the vendor certifying the effectiveness of such solutions, and (z) require the vendors to notify the Company of any security incidents posing a risk to the Company’s information (regardless of whether information was actually compromised). The Company shall evaluate on a periodic basis at least annually whether such safeguards should be updated to maintain a level of security appropriate to the risk posed to Company systems and Protected Data. The Company shall educate its employees about the proper use and storage of Protected Data, including periodic training as determined reasonably necessary by the Company or the Board of Directors.

5.5 Real
Property Holding Corporation. Promptly following (and in any event within ten (10) days after receipt of) written request by an Investor,
the Company shall provide such Investor with a written statement informing such Investor whether such Investor’s interest in the
Company constitutes a United States real property interest. The Company’s determination shall comply with the requirements of Treasury
Regulation Section 1.897-2(h)(1) or any successor regulation, and the Company shall provide timely notice to the Internal Revenue Service,
in accordance with and to the extent required by Treasury Regulation Section 1.897-2(h)(2) or any successor regulation, that such statement
has been made. The Company’s obligation to furnish such written statement shall continue notwithstanding the fact that a class
of the Company’s stock may be regularly traded on an established securities market or the fact that there is no Series A Preferred
Stock then outstanding.

5.6 Anti-Corruption.

(a) The
Company shall take all necessary steps to ensure that the Company and its subsidiaries comply with their social obligations and the following
obligations: (i) not to pay, promise to pay or accept bribes or kickbacks, nor to authorize any person to do so on behalf of the Company
or its subsidiaries; and (ii) to promptly report to the appropriate body any evidence that the Company or any of its subsidiaries or
any person acting on their behalf has paid, promised to pay or accepted bribes or kickbacks or otherwise violated applicable anti-bribery
laws (and ensure that such incidents are fully investigated to the satisfaction of the Board of Directors).

the provisions of Article 17 of the French Law no. 2016-1691 on transparency, the fight against corruption and the modernization of economic
life (the “Sapin II Law”) are applicable to the Company and/or its subsidiaries, the Company declares that
it is in compliance with its obligations, or undertakes to promptly bring the Company into compliance with, in particular, but not exclusively,
the pillars set out in the Sapin II Law. In furtherance of the foregoing, the Company shall promptly:

(i) carry
out a risk mapping to ensure that the corruption risks to which the Company or its subsidiaries is exposed are regularly assessed and
evaluated by a competent body;

(ii) formalize
a code of conduct that includes the measures, principles and preventive procedures to be implemented in the area of anti-corruption;

(iii) set up a whistleblowing system;

(iv) carry
out due diligence on its service providers, intermediaries and suppliers in the fight against corruption;

(v) provide for a disciplinary system for any non-compliant behavior;

(vi) maintain operational accounting control procedures;

(vii) maintain an internal audit system; and

(viii) provide regular training on anti-corruption.

5.7 Anti-Money
Laundering Compliance. The Company shall make available to Andera any information that may be legally required in the future in the
context of the fight against money laundering pursuant to applicable law affecting the Company or Andera. The Company hereby acknowledges
and agrees that Andera is required to report to the competent authorities transactions involving sums which Andera knows, suspects or
has good reason to suspect are the proceeds of an offence punishable by a prison sentence of more than one year or are involved in the
financing of terrorism, as well as any transaction for which the identity of the originator or the beneficial owner or any other instrument
for the management of an earmarked asset remains doubtful despite the diligence Andera and the Company are required to carry out, and
must also refrain from carrying out, under the conditions provided for by law, any operation which they suspect is related to money laundering
or terrorism financing. The Company further acknowledges and agrees that Andera, as well as its management company and/or its management
delegates, are subject to the obligations related to the fight against money laundering and terrorism financing, provided for by the
provisions of sections 2 to 7 of Chapter 1 of Title VI, Book V of the French Monetary and Financial Code and by the provisions of the
AMF General Regulation. (“AML Laws”). Consequently, the Company acknowledges and agrees that, provided that Andera
acts in good faith, Andera, its management company and/or its management delegates shall have the right, if required by applicable AML
Laws, to refuse to perform any of their obligations under this Agreement, to the extent that it is not possible for them to do otherwise
in order to comply with mandatory laws.

5.8 Environmental, Social, and Governance.

(a) The
parties hereto undertake, within the limits of their respective powers, to pay particular attention to ensuring that the Company and
any of its subsidiaries carry out their activities and ensure that their suppliers, subcontractors and service providers, French and
otherwise, take the commitment to carry out their activities:

accordance with the principles of the United Nations Global Compact, the OECD Guidelines and the requirements and recommendations of
the International Labor Organization, in particular the fundamental conventions about freedom of association, non- discrimination, prohibition
of child labor and forced labor;

accordance with professional and ethical rules applicable to the activities of the Company and to all of its subsidiaries, in particular
with regard to the regulations of all applicable public health codes;

(iii) in
a way which avoids, or limits as far as commercially used techniques allow, harm and damage to the environment;

a way which avoids any message that offends common morality or the general principles and rules resulting from the European Convention
for the Protection of Human Rights or Fundamental Liberties; and

(v) which
puts in place appropriate control and monitoring measures related to the Company’s social interests.

(b) The
parties hereto undertake within the limits of their respective powers, financial resources, budget and operational constraints, to be
part of a process of progress aiming at ensuring that the Company and, where applicable, its subsidiaries, carry out their activities
under conditions reconciling the economic interest and the social responsibility thereof.

(c) The
Company will communicate to Investors all environmental, social and governance-related information enabling them to meet their own commitments
in this area and will communicate annually to Investors performance indicators on environmental and social criteria and governance defined
by Investors.

6.	Miscellaneous .

6.1 Successors
and Assigns. The rights under this Agreement may be assigned (but only with all related obligations) by a Holder to a transferee
of Registrable Securities that (i) is an Affiliate of a Holder; or (ii) is a Holder’s Immediate Family Member or trust for the
benefit of an individual Holder or one (1) or more of such Holder’s Immediate Family Members; ; provided, however,
that (x) the Company is, within a reasonable time after such transfer, furnished with written notice of the name and address of such
transferee and the Registrable Securities with respect to which such rights are being transferred; and (y) such transferee agrees in
a written instrument delivered to the Company to be bound by and subject to the terms and conditions of this Agreement, including the
provisions of Section 2.11. For the purposes of determining the number of shares of Registrable Securities held by a transferee,
the holdings of a transferee (1) that is an Affiliate or stockholder of a Holder; (2) who is a Holder’s Immediate Family Member;
or (3) that is a trust for the benefit of an individual Holder or such Holder’s Immediate Family Member shall be aggregated together
and with those of the transferring Holder; provided further that all transferees who would not qualify individually for assignment
of rights shall, as a condition to the applicable transfer, establish a single attorney-in-fact for the purpose of exercising any rights,
receiving notices, or taking any action under this Agreement. The terms and conditions of this Agreement inure to the benefit of and
are binding upon the respective successors and permitted assignees of the parties. Nothing in this Agreement, express or implied, is
intended to confer upon any party other than the parties hereto or their respective successors and permitted assignees any rights, remedies,
obligations or liabilities under or by reason of this Agreement, except as expressly provided herein.